300
Participants
Start Date
July 22, 2025
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2028
Lenacapavir Injection
Administered intramuscularly
Lenacapavir Tablet
Administered orally
RECRUITING
Philadelphia FIGHT Community Health Centers, Jonathan Lax Treatment Center, Philadelphia
NOT_YET_RECRUITING
NC TraCS Institute - CTRC, University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Midway Immunology and Research Center, Ft. Pierce
RECRUITING
Be Well Medical Center, Berkley
RECRUITING
Howard Brown Health Center, Chicago
RECRUITING
The Crofoot Research Center, Houston
RECRUITING
Central Texas Clinical Research, Austin
RECRUITING
Ruane Clinical Research Group, Inc., Los Angeles
RECRUITING
Mills Clinical Research, Los Angeles
RECRUITING
Yale University; School of Medicine; AIDS Program, New Haven
RECRUITING
Fenway Health, Boston
Lead Sponsor
Gilead Sciences
INDUSTRY